Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Posts Net Income in Q3 as Revenue Grows, Spending Shrinks

NEW YORK, Oct. 24 - Invitrogen today said that moderate third-quarter revenue growth atop steep cuts in operating expenses helped the company reach profitability.


For the period ended Sept. 30, Invitrogen reported revenues of $162.6 million, up from $156 million during the same period one year ago. At the same time, R&D spending for the quarter fell to $8.7 million from $9 million in the third quarter 2001 as overall operating expenses in the current quarter shrank to $74.1 million from nearly $126 million one year ago.


The company posted net income of $14.9 million, or $.28 per share, in the current third quarter compared with a net loss of $37.4 million, or $.71 per share, during the same period last year. The company stressed, however, that "the single largest factor" that contributed to the pendulum swing from net loss to net income was the "implementation of FAS No. 142, a rule under which goodwill is no longer amortized."


Invitrogen said it had roughly $626 million cash and cash equivalents as of Sept. 30.


Click here for more information.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.